Bloomberg Six-year-old biotech startup MegaRobo Technologies has raised about $300 million from investors including an arm of Goldman Sachs Group Inc, securing one of the year’s largest Chinese venture capital investments despite a global tech sector rout. Goldman’s private investing arm, venture capital firm GGV Capital and Asia Investment Capital led the Series C round, joined by existing backers ...
Read More »